CCEL Q4 2021 Earnings — Cryo-Cell International, Inc. Revenue & Financial Results | Market Cap Arena

CCELCryo-Cell International, Inc.

$26M

Q4 2021 Earnings

Healthcare Medical - Care Facilities

Income Statement

Revenue

$7M-3.0% YoY

Gross Profit

$5M68.6% margin

Operating Income

-$823,545-11.3% margin

Net Income

-$637,192-8.7% margin

EPS (Diluted)

$-0.07

QoQ Revenue Growth

-2.5%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

$1M

Stock-Based Comp.

$67,747

Balance Sheet

Total Assets

$61M

Total Liabilities

$56M

Stockholders' Equity

$4M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$8M	-3.0%
Gross Profit	$5M	$5M	-4.0%
Operating Income	-$823,545	$2M	-137.8%
Net Income	-$637,192	$1M	-153.1%

Revenue Segments

Processing And Storage Fees

$7M98%

Public Banking

$86,8701%

Product

$55,2001%